Skip to main content
. Author manuscript; available in PMC: 2021 Mar 4.
Published in final edited form as: Semin Oncol. 2020 Mar 4;47(1):23–39. doi: 10.1053/j.seminoncol.2020.02.007

TABLE 1.

Health burdens faced by childhood cancer survivors.

Reference Methods Data Author Conclusion
Armstrong et al3 ■ 14,359 5-year survivors from the Childhood Cancer Survivor Study
■ 1st diagnosed when ≤21 years old
■ 5,604 ≤35 years old (range, 3562 years) at last follow-up
■ Follow-up = median 24.5 years after diagnosis (range, 5–39.3 years)
■ 4,301 siblings.
■ Severe, disabling, life-threatening, and fatal health conditions >5 years from diagnosis classified using CTCAE (version 4.0), grades 3–5
■ By age 50 years, the cumulative incidence of a severe, disabling, life-threatening, or fatal health conditions was greater among survivors than siblings (53.6%, 95%CI 51.5–55.6; v 19.8%, 95%CI 17.0–22.7).
■ Comparing survivors with siblings, hazard ratios (HR) for severe, disabling, life-threatening, or fatal health conditions were significantly increased within:
– Age group 5–19 years (HR 6.8, 95%CI 5.5–8.3)
– Age group of 20–34 years (HR 3.8, 95%CI 3.2–4.5)
– Age group ≥35 years group (HR 5.0, 95%CI 4.1–6.1)
■ HR for severe, disabling, life-threatening, or fatal health conditions significantly higher among those ≥35 years versus those 20–34 years old (P=.03).
■ 25.9% of survivors who reached age 35 years without a previous grade 3/4 condition, experienced a subsequent grade 3–5 condition within 10 years, compared with 6.0% of siblings (P<.001)
■ After fourth decade of life the elevated risk for morbidity and mortality among cancer survivors increases further
Cheung et al4 • 5507 adult survivors in the Childhood Cancer Survivor Study who completed a self-report measure of neurocognitive function
• 47.1% male
• Mean [SD] age at evaluation = 31.8[7.6] years
• Mean [SD] years postdiagnosis 23.1 [4.5] years.
• Cardiac, pulmonary, and endocrine chronic health conditions were graded using NCI CTCAE (v 4.03)
■ 1/3 of survivors with ≥ grade 2 chronic condition reported impairments in task efficiency and memory
■ “Direct effects” on impaired task efficiency seen with
– Cranial radiation
– Cardiopulmonary conditions (β=0.10, P=.002; RR=1.27, 95%CI = 1.12–1.44)
– Endocrine conditions (β = 0.07, P=.04; RR=1.14, 95%CI = 1.02–1.28)
■ Effects on memory and emotional regulations seen with
– Cardiopulmonary conditions [memory (P=.01) and emotional regulation (P=.01).
■ Through endocrine morbidity, thoracic radiation was associated with
– Impaired task efficiency (P=.01)
– Impaired emotional regulation (P=.01)
■ Non-neurotoxic exposures, such as thoracic radiation, can adversely impact survivors’ neurocognitive function through
chronic conditions
■ Management of chronic diseases may mitigate neurocognitive outcomes among aging survivors of childhood cancer
Oancea et al5 ■ 1863 adult survivors of childhood cancer
■ Median age at follow up = of 32 years
■ Completed comprehensive medical evaluations
■ Clinically relevant emotional distress assessed using the Brief Symptom Inventory 18 and defined as T-scores ≥63.
■ Path analysis used to examine associations among identified risk factors
■ 15.1% of survivors reported elevated global distress
■ Cancer-related pain associated with elevated distress (OR 8.72; 95%CI, 5.32–14.31)
■ Compared to survivors who reported no learning or memory problems, survivors who reported moderate learning or memory problems more likely to have elevated distress (OR 3.27; 95%CI, 2.17–4.93)
■ Path analysis implied cancer-related pain has direct effect on distress symptoms and indirect effect through socioeconomic status and learning or memory problems
Childhood cancer-related morbidities including pain and learning or memory problems appear to be directly and indirectly associated with elevated distress symptoms decades after treatment

Abbreviations: CI, confidence interval; CTCAE, Common Terminology Criteria for Adverse Events; HR, hazard ratio; NCI, National Cancer Institute; OR, odds ratio; RR, relative risk